An interventional study of VOX in COVID-19, sponsored by Scentech Medical Technologies Ltd. Completed at 1 site in Israel. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-31.
Sponsored by Scentech Medical Technologies Ltd · Not applicable, Interventional, and Diagnostic
Detection of the 2019 novel Coronavirus (SARS-CoV-2) using breath analysis - Validation study.
A diagnostic prospective single-site study, with no anticipated risks or constraints.
Primary objective- To validate the value of a set of breath VOC biomarkers that enable the investigator to distinguish between COVID-19 carriers and COVID-19 non-carriers in comparison to the gold-standard testing methodology.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 192 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.
Browse COVID-19 studies →Scentech Medical Technologies Ltd is the lead sponsor of 7 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drive In attendees will undergo one breath sampling.
Diagnostic Test: VOX
Healthy attendees will undergo two successive breath sampling.
Diagnostic Test: VOX
Healthy attendees will undergo five successive breath sampling.
Diagnostic Test: VOX
Breath exhalation into the mouthpiece of the VOX breath diagnostic device.
Presence of Volatile Organic Compounds indicating carriers of COVID-19.
Obtain early verification accuracy of measures for a set of VOCs biomarkers indicating carriers of Corona virus.
Time frame: Through the study completion, up to 3 months.
Association of exhaled biomarkers with participants' characteristics (age, gender, symptoms-severity, etc.)
Correlation level between exhaled biomarkers and participants' demographic characteristics.
Time frame: Through the study completion, up to 3 months.
Plan to share: No — No IPD
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scentech Medical Technologies Ltd